Interview Via AI
Artificial intelligence (AI) is finding diverse applications in the Korean bio and pharmaceutical industries. AI is already used in diagnosing diseases and developing new drugs. It is now being applied to work force recruitment by pharmaceutical companies.
According to the pharmaceutical industry on April 26, Hanmi Pharmaceutical will apply AI interviews to the recruitment of new employees in the first half of this year. Anyone who applies for a domestic sales job will be interviewed in front of a computer with a camera. When the computer asks a job applicant a personalized question, the applicant answers and the AI analyzes and evaluates his or her voices, facial expressions, and spoken words. General reviews of AI evaluation and documents will select candidates for the next working group interviews.
"For the first time in the pharmaceutical industry, we introduced AI to assess applicants' aptitudes," a Hanmi Pharmaceutical official said. "We will first apply AI to interviewing sales job applicants that account for the largest number of applicants. All of those who pass document reviews will be subject to AI interviews.”
Hanmi Pharmaceutical operates a large group of salespeople so hundreds of applicants are expected to have AI interviews. It worth watching whether or not AI interviews will spread beyond the information technology (IT) industry to the pharmaceutical industry.
In the bio and pharmaceutical industries, attempts are being made to utilize AI in many sectors in addition to job interviews. A case in point is the introduction of AI to new drug development cut cut down on time and cost. AI plays an active part in the development of new drugs. It is used to find suitable new drug candidates and combine the best compounds for indications.
In advanced foreign countries, AI has already been used ahead of Korea and is yielding meaningful results. The sale of an AI-based medical device that diagnoses diabetic retinopathy was approved by the US Food and Drug Administration (FDA) on April 11. Atomwise, an AI start-up partnering with Merck, found two new drug candidates for Ebola in one day through AI technology.